Altimmune Inc (NASDAQ:ALT) shares, rose in value, with the stock price down by -0.69% to the previous day’s close as strong demand from buyers drove the stock to $9.29.
Actively observing the price movement in the last trading, the stock closed the session at $9.35. The value of beta (5-year monthly) was 0.07. Referring to stock’s 52-week performance, its high was $14.84, and the low was $2.09. On the whole, ALT has fluctuated by -15.93% over the past month.
With the market capitalization of Altimmune Inc currently standing at about $658.66 million, investors are eagerly awaiting this quarter’s results, scheduled for Mar 26, 2024 – Apr 10, 2024. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be -$0.38, which is expected to increase to -$0.3 for fiscal year -$1.22 and then to about -$1.64 by fiscal year 2025. Data indicates that the EPS growth is expected to be 26.50% in 2025, while the next year’s EPS growth is forecast to be -34.40%.
Wall Street analysts also predicted that in 2025, the company’s y-o-y revenues would reach $35.71 million, representing an increase of 8,282.60% from the revenues reported in the last year’s results.
Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were 1 upward and no downward review(s) in last seven days. We see that ALT’s technical picture suggests that short-term indicators denote the stock is a Hold on average. However, medium term indicators have put the stock in the category of 50% Buy while long term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of ALT currently trading nearly -5.09% and -6.50% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 46.65, while the 7-day volatility ratio is showing 13.51% which for the 30-day chart, stands at 9.54%. Furthermore, Altimmune Inc (ALT)’s beta value is 0.08, and its average true range (ATR) is 1.02.
A comparison of Altimmune Inc (ALT) with its peers suggests the former has fared considerably weaker in the market. ALT showed an intraday change of -0.69% in last session, and over the past year, it grew by 120.14%%.
Data on historical trading for Altimmune Inc (NASDAQ:ALT) indicates that the trading volumes over the past 10 days have averaged 4.5 million and over the past 3 months, they’ve averaged 5.98 million. According to company’s latest data on outstanding shares, there are 70.68 million shares outstanding.
Nearly 1.02% of Altimmune Inc’s shares belong to company insiders and institutional investors own 51.25% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 12.51 million shares as on Mar 15, 2024, resulting in a short ratio of 2.01. According to the data, the short interest in Altimmune Inc (ALT) stood at 17.70% of shares outstanding as of Mar 15, 2024; the number of short shares registered in Feb 15, 2024 reached 11.55 million. The stock has fallen by -17.42% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ALT stock heading into the next quarter.
